Market Overview

Wunderlich Securities Reiterates Buy on ABIOMED, Inc., Maintains $29.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ABMD

DateFirmActionFromTo
May 2015Leerink SwannMaintainsOutperform
Jan 2015Northland SecuritiesUpgradesUnderperformMarket Perform
Jan 2015JefferiesMaintainsBuy

View More Analyst Ratings for ABMD
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ABMD)

Get Benzinga's Newsletters